We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.14B
1-Year Est. Return
48.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$224M
AUM Growth
-$7.34M
(-3.2%)
Cap. Flow
-$6.76M
Cap. Flow
% of AUM
-3.02%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
117
New
10
Increased
8
Reduced
37
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$6.31M |
| 2 |
Adobe
ADBE
|
+$3.36M |
| 3 |
Stryker
SYK
|
+$3.14M |
| 4 |
JPMorgan Chase
JPM
|
+$2.44M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVRD
Tvardi Therapeutics
TVRD
|
+$4.16M |
| 2 |
3M
MMM
|
+$4.07M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
+$3.86M |
| 4 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
+$3.8M |
| 5 |
Eaton
ETN
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 25.3% |
| 2 | Healthcare | 20.7% |
| 3 | Energy | 14.37% |
| 4 | Industrials | 12.84% |
| 5 | Technology | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Parker-Hannifin
PH
$125B
| $414K | 0.18% |
3,727
| – | – |
|
77
Netflix
NFLX
$340B
| $386K | 0.17% |
37,750
| – | – |
|
78
Cencora
COR
$61.5B
| $384K | 0.17% |
4,436
| – | – |
|
|
LLL
79
DELISTED
L3 Technologies, Inc.
LLL
| $355K | 0.16% |
3,000
| – | – |
|
80
Bath & Body Works
BBWI
$3.88B
| $351K | 0.16% |
+4,948
| New | +$355K |
|
81
Las Vegas Sands
LVS
$29.2B
| $336K | 0.15% |
+6,500
| New | +$298K |
|
82
Procter & Gamble
PG
$334B
| $335K | 0.15% |
4,065
+65
| +2% | +$5.24K |
|
83
Consolidated Edison
ED
$39.8B
| $333K | 0.15% |
4,350
| – | – |
|
84
IBM
IBM
$222B
| $310K | 0.14% |
2,144
| – | – |
|
85
Walmart Inc
WMT
$820B
| $298K | 0.13% |
13,065
| – | – |
|
|
86
3M
MMM
$89.9B
| $296K | 0.13% |
2,123
-31,664
| -94% | -$4.07M |
|
|
MDSO
87
DELISTED
Medidata Solutions, Inc.
MDSO
| $286K | 0.13% |
7,400
+300
| +4% | +$11.7K |
|
88
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
| $271K | 0.12% |
4,000
| – | – |
|
|
FIT
89
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $258K | 0.12% |
+17,000
| New | +$270K |
|
90
Under Armour
UAA
$2.18B
| $254K | 0.11% |
6,000
| – | – |
|
|
TRIL
91
DELISTED
Trillium Therapeutics Inc.
TRIL
| $231K | 0.1% |
25,000
-451,069
| -95% | -$3.8M |
|
92
Goldman Sachs
GS
$301B
| $224K | 0.1% |
1,425
| – | – |
|
93
Berkshire Hathaway Class B
BRK.B
$1.08T
| $220K | 0.1% |
1,550
| – | – |
|
|
94
Eaton
ETN
$156B
| – | – |
-62,600
| Closed | -$3.26M |
|
95
HCA Healthcare
HCA
$90.5B
| – | – |
-36,665
| Closed | -$2.48M |
|
96
Ionis Pharmaceuticals
IONS
$10.1B
| – | – |
-4,100
| Closed | -$254K |
|
97
PVH
PVH
$3.49B
| – | – |
-3,700
| Closed | -$273K |
|
|
98
Rocket Pharmaceuticals
RCKT
$424M
| – | – |
-85,250
| Closed | -$3.86M |
|
99
Sanofi
SNY
$107B
| – | – |
-62,364
| Closed | -$2.66M |
|
100
Zillow
Z
$8.02B
| – | – |
-16,000
| Closed | -$376K |
|
Similar funds
SC
MIG
PC
RIM
VCP
HGIM
CAM
SIM
Private Capital Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Private Capital Advisors held 117 positions worth $224M, down 3.2% from $232M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Private Capital Advisors withdrew a net $6.76M in Q1 2016, closing 12 positions and reducing 37 holdings. Its most notable exit was Tvardi Therapeutics, an estimated $4.16M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Private Capital Advisors opened a new position in Raytheon Company worth $6.28M.
- Private Capital Advisors's largest Q1 2016 buy was Raytheon Company: 51,240 shares worth $6.28M.
- Private Capital Advisors added most to Alphabet (Google) Class A in Q1 2016, an estimated $1.91M increase.
- Private Capital Advisors's biggest Q1 2016 reduction was 3M, cutting an estimated $4.07M.
- Private Capital Advisors fully exited Tvardi Therapeutics in Q1 2016, selling an estimated $4.16M.
- Private Capital Advisors's ten largest holdings make up 33% of its $224M portfolio in Q1 2016.
- Private Capital Advisors opened 10 new positions and closed 12 in Q1 2016.
- Private Capital Advisors's portfolio value fell 3.2% quarter-over-quarter to $224M.
Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.